
Yi Jin Chief Pharmacist
Shenzhen Institute for Drug Control (Shenzhen Medical Device Testing Center)
Education
Bachelor of Clinical Medicine (6‑year program), Harbin Medical University (1991–1997)
· Ph.D. in Medical Pathology, Nagoya University, Japan (2001–2005)
· Master of Pharmacology, Shenyang Pharmaceutical University (2011–2014)
Professional Experience
· Project Researcher, Faculty of Medicine, The University of Tokyo, Japan (2005–2010)
· Chief Pharmacist, Shenzhen Institute for Drug Control (Shenzhen Medical Device Testing Center) (2014–present)
Professional Affiliations & Academic Appointments
· National Expert in Science and Technology
· GLP Inspector, Center for Food and Drug Inspection, National Medical Products Administration (NMPA)
· Standing Committee Member, Society of Toxicologic Pathology, Chinese Society of Toxicology
· Standing Committee Member, Experimental Pathology Committee, Chinese Association for Laboratory Animal Sciences (CALAS)
· Standing Committee Member, Pathology Equipment Branch, China Association of Medical Equipment; Head, Experimental Pathology Group
· Executive Director, Guangdong Society of Toxicology
· Director, Guangdong Association for Laboratory Animal Science
· First Chairman, Experimental Pathology Committee, Shenzhen Association for Analysis and Testing
· Deputy Secretary‑General (First Committee) and Chairman (Second Committee), Experimental Pathology Committee, Shenzhen Expert and Talent Federation
· External Mentor/Advisor: Tsinghua International Graduate School at Shenzhen, Northwest A&F University, State Key Laboratory of Biotherapy (Sichuan University), Shenzhen University, and others.
Research Projects
· Sub‑project Leader (Pathology), National 14th Five‑Year Key R&D Program of China (2021–2025)
· Head, Key Laboratory of Experimental Pathology, Guangdong Medical Products Administration (2020–2025)
· Led or participated in 13 domestic and international research projects.
Publications & Intellectual Property
· Editor‑in‑Chief: Practical Methods and Techniques in Toxicologic Pathology
· Deputy Chief Translator: Chinese Edition of INHAND (International Harmonization of Nomenclature and Diagnostic Criteria)
· Co‑author / contributor to 10 books
· 47 peer‑reviewed journal articles, over 50 conference papers
· 9 authorized patents, 4 software copyrights
· Co‑established 3 group standards. Awards & Honors
· First Prize of Guangdong Provincial Scientific and Technological Progress Award and five other provincial, ministerial, and municipal awards (total 6 awards)
· 2024 Shenzhen Municipal Government Special Allowance
· Xiehe Award for Excellent Paper, 14th China Experimental Animal Science Annual Conference
